BARNES-JEWISH HOSPITAL
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
About Us
News & Events
Maps & Locations
Contact Us
Google Search
PATIENT AND VISITOR INFORMATION
TREATMENT PROGRAMS
PREVENTION AND SCREENING
RESEARCH
HOW TO HELP
FOR HEALTH PROFESSIONALS
Go back to:
Home
Treatment Programs
Types of Cancer
Clinical Trial Search Results
Share
Pancreatic Cancer
NCI Information
Our Treatment Approach
Clinical Trials
Support Groups
Effects of Treatment
Assess Your Risk
Patient Stories
Podcasts
Videos
Treatment Team
NEW SEARCH
RETURN TO SEARCH RESULTS
Number:
201106364
Principal Investigator:
Wang-Gillam, Andrea
Title:
A Phase 2, Randomized, Multicenter, Open-Label, Study of the Efficacy and Immune Response of the Sequential Administration of GVAX Pancreas Vaccine (with Cyclophosphamide) Alone or Followed by CRS 207 in Adults with Metastatic Pancreatic Adenocarcinoma
Phase:
II
Disease Site:
Pancreas
Participating Site(s):
Main Campus
Map and Directions
Contact:
800-600-3606 or
info@ccadmin.wustl.edu
Description:
The purpose of this research study is to determine whether the study drugs are safe and effective in patients with advanced pancreatic cancer. The drugs to be tested in this study are GVAX pancreas vaccine with low doses of cyclophosphamide and CRS-207.
More Information:
(Links will take you off this web site)
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)